Sales of Plasma Protein Therapeutics to Rise in Response to Increasing Demand for Immunoglobulin.

Albany, NY -- (SBWire) -- 12/11/2017 --Transparency Market Research pegs the global plasma protein therapeutics market to reach US$31.8 bn by the end of 2024, from a valuation of US$18.5 bn in 2015. The market is thus projected to exhibit a CAGR of 7.0% between 2016 and 2024.

Read Report Overview @ https://www.transparencymarketresearch.com/plasma-protein-therapeutics-market.html

The Global Plasma Protein Therapeutics Market is segmented on the basis of expression system, product type, application, end user and region.

Regionally, North America held the dominant share of 40.7% in the global plasma protein therapeutics market in 2015. Intravenous immunoglobulin (IVIG) has emerged as the leading segment in the regional market primarily due to its rising usage in new researches and new indications. The increasing geriatric population, also boosts demand from IVIG from the North America market.

During the same time, Europe held the second largest share in the global plasma protein therapeutics market. The amount of plasma collected and processed in Europe has doubled itself since the last decade. This has augured well for the prospects of plasma protein therapeutics market in Europe. Some of the most lucrative markets for plasma protein therapeutics in Europe include Germany, Italy, Switzerland, France, Spain, Sweden, and the U.K.

However, Asia Pacific has been exhibiting the most attractive opportunities for the global plasma protein therapeutics market. The region is expected to demonstrate the highest CAGR of all between 2016 and 2024. TMR projects the regional market to rise at a CAGR of 8.1% during the forecast period.

By product, immunoglobulin emerged dominant, holding a share of 40% in the plasma protein therapeutics market in 2015. The demand for immunoglobulin has been increasing in response to the surging production of plasma-based drugs. Since these drugs are found quite efficient in the treatment of primary immunodeficiency diseases, demand from the product segment is likely to continue increasing at a robust pace through the forecast period.

By application, use of plasma protein therapeutics is expected to rise in the treatment of both primary and secondary immunodeficiency disorders.

Request A Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10424

Summary of Table of Content

Preface

Executive Summary

Global Plasma Protein Therapeutics Market Revenue Analysis, 2014–2024 (US$ Mn)

North America Plasma Protein Therapeutics Market Revenue Analysis, 2014–2024 (US$ Mn)

Europe Plasma Protein Therapeutics Market Revenue, 2014–2024 US$ Mn)

Asia Pacific Plasma Protein Therapeutics Market Revenue Analysis, 2014–2024 (US$ Mn)

Latin America Plasma Protein Therapeutics Revenue Analysis, 2014–2024 (US$ Mn)

Rest of the World (RoW) Plasma Protein Therapeutics Market Revenue
Analysis, 2014–2024 (US$ Mn)

Company Profiles

Get Full Report@ https://www.transparencymarketresearch.com